|
Sign In to gain access to subscriptions and/or personal tools.
|
Integrative Cancer Therapies, Vol. 5, No. 4,
362-372 (2006)
DOI: 10.1177/1534735406295350
© 2006 SAGE Publications
Effects of Homeopathic Preparations on Human Prostate Cancer Growth in Cellular and Animal Models
Brian W. MacLaughlin, BS
Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC
Babett Gutsmuths, PharmD, PhD
Ewald Pretner, MD
Department of Cell Biology, Georgetown University Medical Center, Washington, DC
Wayne B. Jonas, MD
John Ives, PhD
Samueli Institute for Information Biology, Alexandria, VA
Don Victor Kulawardane, MD, DTH, DCH
Homeopathic Clinic, Jayawardane Place, Dehiwala, Sri Lanka
Hakima Amri, PhD
Department of Physiology and Biophysics, Basic Science Building, room 217, Georgetown University Medical Center, 3900 Reservoir Rd, NW, Washington, DC 20007 amrih{at}georgetown.edu
The use of dietary supplements for various ailments enjoys unprecedented popularity. As part of this trend, Sabal serrulata (saw palmetto) constitutes the complementary treatment of choice with regard to prostate health. In homeopathy, Sabal serrulata is commonly prescribed for prostate problems ranging from benign prostatic hyperplasia to prostate cancer. The authors' work assessed the antiproliferative effects of homeopathic preparations of Sabal serrulata, Thuja occidentalis, and Conium maculatum, in vivo, on nude mouse xenografts, and in vitro, on PC-3 and DU-145 human prostate cancer as well as MDA-MB-231 human breast cancer cell lines. Treatment with Sabal serrulata in vitro resulted in a 33% decrease of PC-3 cell proliferation at 72 hours and a 23% reduction of DU-145 cell proliferation at 24 hours (P<.01). The difference in reduction is likely due to the specific doubling time of each cell line. No effect was observed on MDA-MB-231 human breast cancer cells. Thuja occidentalis and Conium maculatum did not have any effect on human prostate cancer cell proliferation. In vivo, prostate tumor xenograft size was significantly reduced in Sabal serrulatatreated mice compared to untreated controls (P=.012). No effect was observed on breast tumor growth. Our study clearly demonstrates a biologic response to homeopathic treatment as manifested by cell proliferation and tumor growth. This biologic effect was (i)significantly stronger to Sabal serrulata than to controls and (ii)specific to human prostate cancer. Sabal serrulata should thus be further investigated as a specific homeopathic remedy for prostate pathology.
Key Words: prostate cancer Sabal serrulata Thuja occidentalis Conium maculatum human prostate breast cancer cell lines nude mice
References
- Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2005.
- Dearnaley DP, Sydes MR, Mason MD, et al. A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). J Natl Cancer Inst. 2003;95(17):1300-1311.[Abstract/Free Full Text]
- Hamdy FC. Prognostic and predictive factors in prostate cancer. Cancer Treat Rev. 2001;27(3):143-151.[CrossRef][Medline]
[Order article via Infotrieve]
- Kronz JD, Milord R, Wilentz R, Weir EG, Schreiner SR, Epstein JI. Lesions missed on prostate biopsies in cases sent in for consultation. Prostate. 2003;54(4):310-314.[CrossRef][Medline]
[Order article via Infotrieve]
- Wei J, Gravlin K, Cooney KA. Re: Osteoporosis after orchiectomy for prostate cancer. J Urol. 1998;160(5):1809-1809.[CrossRef][Medline]
[Order article via Infotrieve]
- Deftos LJ. Prostate carcinoma: production of bioactive factors. Cancer. 2000;88(12 Suppl):3002-3008.[CrossRef][Medline]
[Order article via Infotrieve]
- Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349(4):366-381.[Free Full Text]
- Farnsworth NR, Morris RW. Higher plantsthe sleeping giant of drug development. Am J Pharm Sci Support Public Health. 1976;148(2):46-52.[Medline]
[Order article via Infotrieve]
- Barberis L, de Toni E, Schiavone M, Zicca A, Ghio R. Unconventional medicine teaching at the Universities of the European Union. J Altern Complement Med. 2001;7(4):337-343.[CrossRef][Medline]
[Order article via Infotrieve]
- Fisher P. Homeopathy: a multifaceted scientific renaissance. J Altern Complement Med. 2001;7(2):123-125.[CrossRef][Medline]
[Order article via Infotrieve]
- Davenas E, Beauvais F, Amara J, et al. Human basophil degranulation triggered by very dilute antiserum against IgE. Nature. 1988;333(6176):816-818.[CrossRef][Medline]
[Order article via Infotrieve]
- Hirst SJ, Hayes NA, Burridge J, Pearce FL, Foreman JC. Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature. 1993;366(6455):525-527.[CrossRef][Medline]
[Order article via Infotrieve]
- Belon P, Cumps J, Ennis M, et al. Histamine dilutions modulate basophil activation. Inflamm Res. 2004;53(5):181-188.[CrossRef][Medline]
[Order article via Infotrieve]
- Lorenz I, Schneider EM, Stolz P, Brack A, Strube J. Influence of the diluent on the effect of highly diluted histamine on basophil activation. Homeopathy. 2003;92(1):11-18.[CrossRef][Medline]
[Order article via Infotrieve]
- Lapp C, Wurmser L, Ney J. Infinitesimal doses of sodium arseniate causing mobilization of fixed arsenic in guinea pigs. Therapie. 1955;10(4):625-638.[Medline]
[Order article via Infotrieve]
- Cazin JC, Cazin M, Gaborit JL, et al. A study of the effect of decimal and centesimal dilutions of arsenic on the retention and mobilization of arsenic in the rat. Hum Toxicol. 1987; 6(4):315-320.[Medline]
[Order article via Infotrieve]
- Bildet J, Guere JM, Saurel J, Aubin M, Demerque D, Quilichini R. Etude de l'action de differentes dilutions de phosphorus sur l'hepatite toxique du rat. Ann Homeop Fr. 1975;17(4):425-430.
- Bildet J, Aubin M, Baronnet S, Berjon JJ, Gomez H, Manlhiot JL. Resistance de la cellule hepatique du rat apres une intoxication infinitesimale au tetrachlorure de carbone. Homeop Francaise. 1984;72:211-216.
- Cambar J, Desmouliere A, Cal JC, Guillemain J. Mise en evidence de l'effet protecteur de dilutions homeopathiques de Mercurius corrosivus vis-a-vis de la mortalite au chlorure mercurique chez la souris. Ann Homeop Fr. 1983;25(5):160-165.
- Bastide P, Aubin M, Baronnet S. Etude pharmacologique d'une preparation d'Apis mel. (7CH) vis-a-vis de l'erytheme aux rayons UV chez le cobayes albinos. Ann Homeop Fr. 1975; 17(3):289-294.
- Bildet J, Guyot M, Bonini F, Grignon MC, Pointevin B, Quilichini R. Demonstrating the effects of Apis mellifica and Apium virus dilutions on erythema induced by UV radiation on guinea pigs. Berlin J Res Homeop. 1990;1:28-36.
- Delbancut A, Dorfman P, Cambar J. Protective effect of very low concentrations of heavy metals (cadmium and cisplatin) against cytotoxic doses of these metals on renal tubular cell cultures. Br Homeop J. 1993;82:123-129.
- Jonas W, Lin Y, Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport. 2001;12(2): 335-339.[CrossRef][Medline]
[Order article via Infotrieve]
- Pathak S, Multani AS, Banerji P, Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol. 2003;23(4):975-982.[Medline]
[Order article via Infotrieve]
- Biswas SJ, Khuda-Bukhsh AR. Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice. BMC Complement Altern Med. 2002;2:4-4.[CrossRef][Medline]
[Order article via Infotrieve]
- Biswas SJ, Pathak S, Bhattacharjee N, Das JK, Khuda-Bukhsh AR. Efficacy of the potentized homeopathic drug, Carcinosin 200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p-dimethylaminoazobenzene-induced hepatocarcinogenesis in mice. J Altern Complement Med. 2005;11(5):839-854.[CrossRef][Medline]
[Order article via Infotrieve]
- Sato DY, Wal R, de Oliveira CC, et al. Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy. 2005;94(1):26-32.[CrossRef][Medline]
[Order article via Infotrieve]
- Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate. 1996;29(4):231-240; discussion 41-42.[CrossRef][Medline]
[Order article via Infotrieve]
- Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology. 1998;51(6):1003-1007.[CrossRef][Medline]
[Order article via Infotrieve]
- Gerber GS, Fitzpatrick JM. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int. 2004;94(3):338-344.[CrossRef][Medline]
[Order article via Infotrieve]
- Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354(6):557-566.[Abstract/Free Full Text]
- Richardson MA, White JD. Complementary/alternative medicine and cancer research. A national initiative. Cancer Pract. 2000;8(1):45-48.[CrossRef][Medline]
[Order article via Infotrieve]
- Kao GD, Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer. 2000;88(3):615-619.[CrossRef][Medline]
[Order article via Infotrieve]
- Blumenthal M. The Complete German Commission E Monographs Therapeutic Guide to Herbal Medicines. 1st ed. Austin, TX: American Botanical Council; 1998.
- Vozianov AF, Simeonova NK. [Homeopathic treatment of patients with prostate gland adenoma]. Vrach Delo. 1989(2):5-8.[Medline]
[Order article via Infotrieve]
- Pecherskii AV, Aleksandrov VP, Mazurov VI, Kniaz'kin IV, Zeziulin PN, Nikolaeva EV. [Treatment of benign prostatic hyperplasia with the preparation Gentos]. Urologiia. 2000(5): 16-17.
- Baran D. [Arbor vitae, a guarantee of health]. Rev Med Chir Soc Med Nat Iasi. 1991;95(3-4):347-349.[Medline]
[Order article via Infotrieve]
- Gohla SH, Zeman RA, Bogel M. Modification of the in vitro replication of the human immunodeficiency virus HIV-1 by TPSg, a polysaccharide fraction isolated from the Cupressaceae Thuja occidentalis L. (Arborvitae). Haematol Blood Transfus. 1992; 35:140-149.
- Gohla SH, Haubeck HD, Neth RD. Mitogenic activity of high molecular polysaccharide fractions isolated from the Cupressaceae Thuja occidentale L. I. Macrophage-dependent induction of CD-4-positive T-helper (Th+) lymphocytes. Leukemia. 1988;2(8): 528-533.[Medline]
[Order article via Infotrieve]
- Naser B, Bodinet C, Tegmeier M, Lindequist U. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. eCAM. 2005;2(1):69-78.
- Sunila E, Kuttan G. Protective effect of Thuja occidentalis against radiation-induced toxicity in mice. Integr Cancer Ther. 2005;4(4):322-328.[Abstract]
- Iwamoto M, Minami T, Tokuda H, Ohtsu H, Tanaka R. Potential antitumor promoting diterpenoids from the stem bark of Thuja standishii. Planta Med. 2003;69(1):69-72.[CrossRef][Medline]
[Order article via Infotrieve]
- Valsa JO, Felzenszwalb I. Genotoxic evaluation of the effect of Thuya occidentalys tinctures. Braz J Biol. 2001;61(2):329-332.[Medline]
[Order article via Infotrieve]
- Vetter J. Poison hemlock (Conium maculatum L.). Food Chem Toxicol. 2004;42(9):1373-1382.[CrossRef][Medline]
[Order article via Infotrieve]
- Herscu P, Ryan C. The cycle of Conium maculatum. N Engl J Homeop. 1997;6(1). Available at: www.nesh.com/main/nejh/samples/conium.html.
- Reynolds T. Hemlock alkaloids from Socrates to poison aloes. Phytochemistry. 2005;66(12):1399-1406.[CrossRef][Medline]
[Order article via Infotrieve]
- Cooper D. Origin and history of carcinosin. Br Homeop J. 1982;71(10):20-20.
- Smits T, ed. Pratcical Materia Medica for the consulting room. 2nd ed. Waalre, Netherlands: Smits-Vanhove; 1993.
- Gaddipati JP, Mani H, Shefali, et al. Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). Anticancer Res. 2000;20(4): 2547-2552.[Medline]
[Order article via Infotrieve]
- Stephenson J. Review of investigations into the action of substances in dilutions greater than 1 x 10(-24) (microdilutions). Br Homeop J. 1973;62:3-18.[CrossRef]
- Witt C. Using Methods of Physics to Study Homeopathic High Potencies. Essen, Germany: KVC Verlag; 2000.
- Zacharias C. Implications of contaminants to scientific research in homeopathy. Br homeopathic J. 1995;84:3-5.[CrossRef]
- Witt CM, Ludtke R, Weisshuhn TE, Quint P, Willich SN. The role of trace elements in homeopathic preparations and the influence of container material, storage duration, and potentisation. Forsch Komplementarmed. 2006;13(1):15-21.[CrossRef][Medline]
[Order article via Infotrieve]
- Demangeat J, Gries P, Pointevin B. Low-field NMR water proton longitudinal relaxation in ultrahigh diluted aqueous solutions of silica-lactose prepared in glass material for pharmaceutical use. Appl Magnet Resonance. 2004;26:465-481.
- Jonas W, Dillner D. Protection of mice from tularemia infection with ultra-low, serial agitated dilutions prepared from Francisella tularensis-infected tissue. J Sci Explor. 2000;14: 35-52.
- Aabel S, Fossheim S, Rise F. Nuclear magnetic resonance (NMR) studies of homeopathic solutions. Br Homeopath J. 2001;90(1):14-20.[CrossRef][Medline]
[Order article via Infotrieve]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Bhattacharjee, S. Pathak, and A. R. Khuda-Bukhsh
Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200
Evid. Based Complement. Altern. Med.,
June 19, 2007;
(2007)
nem067v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|